Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
124,3 USD | -9,91% | -4,87% | +0,20% |
26/04 | DEXCOM, INC. : Morgan Stanley conferma il rating Buy | ZM |
26/04 | DEXCOM, INC. : Canaccord Genuity conferma il giudizio Neutral | ZM |
Attività
Gli Stati Uniti rappresentano il 72,5% delle vendite nette.
Numero di dipendenti: 9 550
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Distributor
85,5
%
| 2 471 | 84,9 % | 3 096 | 85,5 % | +25,29% |
Direct
14,5
%
| 439 | 15,1 % | 527 | 14,5 % | +19,98% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
72,5
%
| 2 142 | 73,6 % | 2 625 | 72,5 % | +22,56% |
International
27,5
%
| 768 | 26,4 % | 997 | 27,5 % | +29,85% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01/11/07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01/09/18 |
Chief Tech/Sci/R&D Officer | 47 | 01/10/22 | |
Shelly Selvaraj
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/05/16 |
Jacob Leach
COO | Chief Operating Officer | 46 | 01/03/04 |
Don Abbey
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/05/16 |
Andrew Balo
CTO | Chief Tech/Sci/R&D Officer | 76 | 01/02/02 |
Sean Christensen
IRC | Investor Relations Contact | - | - |
Paul Flynn
PRN | Corporate Officer/Principal | 55 | 01/10/15 |
Sadie Stern
HRO | Human Resources Officer | 49 | 01/09/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20/11/09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19/11/14 |
Eric Topol
BRD | Director/Board Member | 69 | 09/07/09 |
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01/11/07 |
Steven Altman
BRD | Director/Board Member | 62 | 07/11/13 |
Bridgette Heller
BRD | Director/Board Member | 62 | 13/09/19 |
Richard Collins
BRD | Director/Board Member | 67 | 09/03/17 |
Kyle Malady
BRD | Director/Board Member | 56 | 11/10/20 |
Barbara Kahn
BRD | Director/Board Member | 71 | 01/04/11 |
Karen Dahut
BRD | Director/Board Member | 60 | 11/08/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 410 083 837 | 394 607 268 ( 96,23 %) | 12 400 000 ( 3,024 %) | 96,23 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Dexcom Operating Ltd.
Dexcom Operating Ltd. Financial ConglomeratesFinance Part of DexCom, Inc., DexCom Operating Ltd. functions as an investment holding British company. The private company is based in Reading, UK and was founded in 2015. |
Financial Conglomerates
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+0,20% | 49,45 Mrd | |
-2,31% | 187 Mrd | |
-3,20% | 106 Mrd | |
-5,04% | 66,9 Mrd | |
+17,29% | 48 Mrd | |
+4,06% | 40,84 Mrd | |
+2,36% | 26,25 Mrd | |
+2,07% | 26,48 Mrd | |
+12,96% | 24,62 Mrd | |
-1,93% | 24,52 Mrd |
- Borsa valori
- Azioni
- Azione DXCM
- Società DexCom, Inc.